Literature DB >> 1842734

Calcium phosphate, bile acids and colorectal cancer.

R Van der Meer1, J H Kleibeuker, J A Lapré.   

Abstract

The biochemical and nutritional studies discussed here are consistent with the model presented in Figure 1. As shown in vitro, bile acids are precipitated by insoluble calcium phosphate. This calcium phosphate dependent precipitation drastically inhibits their cytotoxicity. A diet-induced increase in luminal surfactant concentration stimulates lytic activity of faecal water and intestinal cell damage resulting in an increased proliferation. The increase in luminal surfactant concentration and lytic activity of faecal water can be counteracted by supplemental dietary calcium phosphate. Supplemental calcium in humans increases the formation of insoluble calcium-phosphate-bile acid complexes in faeces, decreases the soluble fatty acid concentration and decreases lytic activity of faecal water. This sequence of effects offers a molecular explanation of the protective effects of supplemental calcium on proliferation as frequently observed (see studies cited above). It should be realised that this chain of evidence still lacks final proof of a preventive effect of dietary calcium on colorectal cancer. Until now, only protective effects on the first stage of development of colorectal cancer (hyperproliferation) have been observed. More well-designed studies in patients and healthy volunteers are needed using a combined biochemical, nutritional and clinical approach to elucidate the complex mechanism of the protective effect of calcium on colon cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1842734     DOI: 10.1097/00008469-199110002-00010

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

1.  Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins.

Authors:  Aaron Goldberg; Richard D Gerkin; Michele Young
Journal:  Dig Dis Sci       Date:  2015-02-14       Impact factor: 3.199

2.  Relationship between serum calcium and CA 19-9 levels in colorectal cancer.

Authors:  Peter Fuszek; Peter Lakatos; Adam Tabak; Janos Papp; Zsolt Nagy; Istvan Takacs; Henrik Csaba Horvath; Peter Laszlo Lakatos; Gabor Speer
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

3.  Quantitative assessment of the clinical susceptibility of calcium-sensing receptor polymorphisms in cancer patients.

Authors:  Haohai Huang; Tao Li; Dan Liao; Zhu Zhu; Yong Dong
Journal:  Cancer Manag Res       Date:  2018-04-12       Impact factor: 3.989

Review 4.  Associations between nutritional factors and KRAS mutations in colorectal cancer: a systematic review.

Authors:  Achraf El Asri; Btissame Zarrouq; Khaoula El Kinany; Laila Bouguenouch; Karim Ouldim; Karima El Rhazi
Journal:  BMC Cancer       Date:  2020-07-28       Impact factor: 4.430

5.  Association between CASR polymorphisms, calcium intake, and colorectal cancer risk.

Authors:  Kyee-Zu Kim; Aesun Shin; Jeongseon Kim; Ji Won Park; Sung Chan Park; Hyo Seong Choi; Hee Jin Chang; Dae Yong Kim; Jae Hwan Oh
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  Does dietary calcium interact with dietary fiber against colorectal cancer? A case-control study in Central Europe.

Authors:  Aleksander Galas; Malgorzata Augustyniak; Elzbieta Sochacka-Tatara
Journal:  Nutr J       Date:  2013-10-04       Impact factor: 3.271

7.  Calcium and Phosphate Metabolism, Blood Lipids and Intestinal Sterols in Human Intervention Studies Using Different Sources of Phosphate as Supplements-Pooled Results and Literature Search.

Authors:  Ulrike Trautvetter; Bianka Ditscheid; Gerhard Jahreis; Michael Glei
Journal:  Nutrients       Date:  2018-07-20       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.